Targeting Ovarian Carcinoma with TSP-1:CD47 Antagonist TAX2 Activates Anti-Tumor Immunity.
Jeanne A, Sarazin T, Charlé M, Moali C, Fichel C, Boulagnon-Rombi C, Callewaert M, Andry MC, Diesis E, Delolme F, Rioult D, Dedieu S.
Jeanne A, et al. Among authors: rioult d.
Cancers (Basel). 2021 Oct 7;13(19):5019. doi: 10.3390/cancers13195019.
Cancers (Basel). 2021.
PMID: 34638503
Free PMC article.